DermaBio

An action-packed week in #Pittsburgh for the DermaBio team! 🤩 🌟 Time together at the AlphaLab Health office for Miriam Oron Ph.D. Meital Portugal, PhD and Maura Rosenfeld. Ann Deren-Lewis will join us next time! 🌟 The Innovation Works Venture Expo Jeanne Colwell Iasella Maria Geraghty Jordan Marinkovich, MBA Ven Raju Kirk Botula 🌟 Meeting with advisors and collaborators Jeff Cohen Matthew Bauer Laura Ohlund Dave Colaizzi Aaron Schnizer Annie Shaw 🌟 Lots of good meals 🍱🍝🍷and good company Ketaki Desai, PhD Shira Mingelgrin

Shout out to Innovation Works for hosting the Venture Expo 2025 yesterday! We appreciated the opportunity to present DermaBio. Thank you to the IW team for their hard work in making this happen! Miriam Oron Ph.D. Meital Portugal, PhD Maura Rosenfeld Ann Deren-Lewis Jeanne Colwell Iasella Maria Geraghty Jordan Marinkovich, MBA Matthew Bauer Jeff Cohen Sara Longo, PMP Damon Claus Aaron Tainter Ketaki Desai, PhD Cristina M. Ramirez Wendy McSparren Abraham Lin Tyler Gilcrest Sophia Fang Becca Segel, PhD Rakshit Sharma, MD, MBA Dave Colaizzi Mara McFadden Cristina M. Ramirez

We’re excited to share our latest review paper co-authored by our CTO, Meital Portugal, PhD, on innovative skin models for allergic and irritant contact dermatitis research: Requirements for alternative in vitro and in silico skin models of irritant and allergic contact dermatitis, Horizon Europe COST Action NETSKINMODELS (CA21108) Contact Dermatitis (CD)—both irritant and allergic, is among the most common inflammatory skin conditions globally. Triggered by direct contact with irritants or allergens, CD leads to redness, swelling, oozing, and pain. This paper reviews the current landscape of alternative models that aim to replace or reduce animal testing in CD research, including: - In vitro and ex vivo systems - Organoid models -In silico simulations We highlight how these models, together with their associated biomarkers, mimic key features of human skin to improve our understanding of inflammation, immune responses, and skin barrier disruption. At DermaBio, we are committed to advancing dermatological research by integrating biomarker-driven approaches and cutting-edge models to enable more predictive, personalized solutions. Warangkana Lohcharoenkal, Evelyn Kelemen, Inge Kortekaas Krohn, Shauni De Vriese, Danuta Gutowska-Owsiak, Ivone Jakasa, Dijana Furundžić, Anna zalewska-Janowska Sandrine Dubrac Miriam Oron Ph.D. Ann Deren-Lewis Maura Rosenfeld DOMINIC WEILBAECHER #precisionmedicine #biomarker

🌟 Milestone Achieved! 🌟 We successfully completed our clinical study on 100 children with atopic dermatitis at Schneider Children's Medical Center of Israel! This research marks a significant step in demonstrating the power of skin biomarkers in clinical practice. A huge thank you to Dr. Rivka Friedman, MD and Yael Renert-Yuval, MD for leading this research. We are incredibly grateful for their expertise and commitment to advancing pediatric dermatology. 🔬 Stay tuned for the results! Miriam Oron Ph.D. Meital Portugal, PhD Maura Rosenfeld Ann Deren-Lewis DOMINIC WEILBAECHER Sivan Sadan Zvika Shinar Dov Tamarkin Dan Shwarzman Dalia Mor Jeanne Colwell Iasella Jeff Cohen #AtopicDermatitis #SkinBiomarkers #Autoimmunediseases #PrecisionMedicine

Upcoming webinar on FeMmune December 5 at 12:00 PM ET! 📣 Join us for an engaging discussion about autoimmune diseases and women's health. You can register now and get it on your calendar! Our wonderful speakers are Rachel Braun Scherl Bonnie Feldman and Jennifer Grier. They will explore how autoimmune diseases are a women's health issue, how to improve care and how to account for sex and gender differences. You can register here: https://bit.ly/3CL0je6 Brought to you by FeMmune NOGAFem and DermAb.io Miriam Oron Ph.D. Meital Portugal, PhD Kathrin Schoenborn Ronell Klingman Dr. Michal Sela

Miriam Oron Ph.D. will be presenting DermAb.io  alongside esteemed speakers Hadas Ziso Daniella Gilboa and Avital Adler, PhD at the upcoming New England - Israel Business Council webinar ! Meital Portugal, PhD Maura Rosenfeld MindUP - The Digital Health Incubator Viki Gronau, MBA

💡 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐰𝐨𝐦𝐞𝐧'𝐬 𝐡𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐜𝐮𝐭𝐭𝐢𝐧𝐠-𝐞𝐝𝐠𝐞 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧? 𝐓𝐡𝐢𝐬 𝐢𝐬 𝐚𝐧 𝐞𝐯𝐞𝐧𝐭 𝐲𝐨𝐮 𝐝𝐨𝐧’𝐭 𝐰𝐚𝐧𝐭 𝐭𝐨 𝐦𝐢𝐬𝐬! Join our CEO Miriam Oron Ph.D. on Thursday, October 17 for a virtual event hosted by Women of Wearables. Miriam will share DermAb.io’s pioneering approach to personalized biologic therapies that address the unique needs of women with autoimmune diseases. With a focus on reducing the trial-and-error process of treatments, our technology is bringing better healthcare outcomes to women everywhere. 📅 Date: Thursday, October 17 🕕 Time: 6 - 8pm IDT 📍 Location: Online 🔗 𝐒𝐚𝐯𝐞 𝐲𝐨𝐮𝐫 𝐬𝐩𝐨𝐭 𝐭𝐨𝐝𝐚𝐲 𝐚𝐧𝐝 𝐞𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐰𝐨𝐦𝐞𝐧’𝐬 𝐡𝐞𝐚𝐥𝐭𝐡 >> https://lnkd.in/dYaCDJCQ #WomensHealth #Biotech #Innovation #AutoimmuneTherapies Meital Portugal, PhD, Maura Rosenfeld, Sivan Sadan, Ludmila LE GOHEBEL, Ann Deren-Lewis, MindUP - The Digital Health Incubator, FEMMUNE

Register today for the upcoming FEMMUNE webinar! https://lnkd.in/dC9U9SzP Viki Gronau, MBA #womenhealth #autoimmune #Femtech

Many intrinsic processes and pathologies are reflected in the skin, either clinically by cutaneous symptoms or sub-clinically by alterations in skin biomarkers. DermAb.io’s skin biomarker platform leverages information from human skin to predict response to biological drugs used to treat autoimmune and chronic diseases.  Our mission is to allow providers to prescribe the right drug for their patients the first time, bringing significant savings to payers and relief to patients.   Thank you NoCamels - Israeli Tech & Innovation News for providing this stage to DermAb.io https://lnkd.in/dMZa5yzu   Miriam Oron Ph.D. Meital Portugal, PhD Maura Rosenfeld Ann Deren-Lewis MindUP - The Digital Health Incubator Sivan Sadan Kathrin Schoenborn Ludmila Livertovsky FEMMUNE Viki Gronau, MBA   #autoimmune #autoimmunediseases #womenshealth

The month of August is Psoriasis Awareness Month, a chance to raise awareness about a condition that affects more than 8 million Americans. Psoriasis speeds up skin cell growth, leading to itchy, scaly patches that can show up just about anywhere. It’s more than skin-deep, though—it can also bring joint pain and other health issues along for the ride. There are five types of psoriasis, with plaque psoriasis being the most common. It often starts between ages 15 and 25 but can happen at any age. While the exact cause is still a mystery, the immune system and genetics definitely play key roles. DermAb.io is stepping up with a clinical decision support tool that helps doctors prescribe the right biologic therapy for chronic and autoimmune diseases like psoriasis. Our non-invasive tech painlessly retrieves biomarkers from the skin’s surface, providing valuable insights that help doctors pick the most effective treatment from the get-go. This means less trial and error, saving time, costs, and a lot of discomfort. https://lnkd.in/dkDGhmWv #PsoriasisAwarenessMonth #Psoriasis #AutoimmuneDisease #HealthcareInnovation Meital Portugal, PhD Miriam Oron Ph.D. MindUP - The Digital Health Incubator Maura Rosenfeld Ann Deren-Lewis Ludmila Livertovsky